✉news ScienceScience first seen 7 h ago, last 1 h ago, peak #15
Kodiak Sciences Soars 150% After Drug Trial Success
Original: Kodiak Sciences Up 150% At Opening Bell After Drugs Pass Key Trial
Kodiak Sciences shares jumped roughly 150% at the opening bell after the biotech's drug passed a key clinical trial. The strong trial results triggered a sharp rally in the stock, making the eye-disease drug developer one of the day's biggest gainers and drawing investor attention to its pipeline prospects.
Why now: Positive clinical trial results caused a dramatic single-day surge in the company's stock.
Rank over time, top of the chart is #1. 6 snapshots from 7 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/250062